|February 13, 2014|
|07:13 EDT||CNMD||CONMED reports Q4 adjusted EPS 53c, consensus 49c|
Reports Q4 revenue $203.4M, consensus $197.24M.
News For CNMD From The Last 14 Days
|January 28, 2015|
|08:23 EDT||CNMD||CONMED price target raised to $56 from $46 at Summer Street|
Summer Street raised its price target for CONMED shares to $56 following the company's Q4 results and reiterates a Buy rating on the stock.
|January 27, 2015|
|16:27 EDT||CNMD||CONMED sees revenue growth accelerating in 2H15|
CONMED has outlined certain changes in the structure of its commercial organization that management believes will return the company to sales growth in 2015. The company anticipates constant currency sales growth of 1% to 3% for the full year, which will be driven by new product launches and a reorganization of certain aspects of the commercial sales organization in early 2015. As a result, management expects revenue growth to accelerate in the second half of 2015 compared to the first half of 2015.
|16:05 EDT||CNMD||CONMED sees FY15 adjusted EPS $1.82-$1.92, consensus $2.02|
Sees FY15 revenue $727M-$742M, consensus $749.92M.
|16:04 EDT||CNMD||CONMED sees FY15 constant currency sales growth of 1%-3% |
Subscribe for More Information
|16:03 EDT||CNMD||CONMED reports Q4 adjusted EPS 53c, consensus 54c|
Reports Q4 revenue $195M, consensus $196M.